Guidance for industry: drug interaction studies – study design, data analysis, implications for dosing, and labeling recommendations, U.S - Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and Research (CDER) (CDER, FDA, 2012)